Association between obesity, sex, medical comorbidities, and survival in cancer patients treated with immune checkpoint inhibitors.

Saved in:
Bibliographic Details
Title: Association between obesity, sex, medical comorbidities, and survival in cancer patients treated with immune checkpoint inhibitors.
Authors: Li M; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, USA., Spakowicz DJ; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, USA.; Pelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, USA., Zhao S; Department of Biomedical Informatics, Center for Biostatistics, The Ohio State University, Columbus, USA., Kwon H; Pelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, USA.; Department of Internal Medicine, The Ohio State University, Columbus, USA., Chian K; College of Medicine, The Ohio State University, Columbus, USA., Khorasanchi A; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, USA., Guo Y; College of Pharmacy, The Ohio State University, Columbus, USA., Wei L; Department of Biomedical Informatics, Center for Biostatistics, The Ohio State University, Columbus, USA., Meng L; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, USA.; Pelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, USA., Yang Y; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, USA.; Pelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, USA., Alahmadi A; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, USA., Memmott RM; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, USA., Kaufman J; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, USA.; Pelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, USA., He K; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, USA.; Pelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, USA., Shields PG; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, USA.; Pelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, USA., Mace TA; Division of Gastroenterology Hepatology and Nutrition, Department of Internal Medicine, The Ohio State University, Columbus, USA., Phelps MA; College of Pharmacy, The Ohio State University, Columbus, USA., Coss CC; College of Pharmacy, The Ohio State University, Columbus, USA., Li Z; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, USA.; Pelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, USA., Kendra KL; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, USA., Carbone DP; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, USA.; Pelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, USA., Otterson GA; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, USA., Presley CJ; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, USA.; Pelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, USA., Owen DH; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, USA.; Pelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, USA.
Source: Journal of Cancer [J Cancer] 2026 Jun 10; Vol. 17 (6), pp. 1117-1124. Date of Electronic Publication: 2026 Jun 10 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101535920 Publication Model: eCollection Cited Medium: Print ISSN: 1837-9664 (Print) Linking ISSN: 18379664 NLM ISO Abbreviation: J Cancer Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1837-9664
DOI:10.7150/jca.130032